Literature DB >> 2184137

Increase in specific antibody-forming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccine.

G C Faure1, M C Béné, C Simon, A Quantain.   

Abstract

Thirty subjects who had received an oral ribosomal vaccine to common bacteria of upper respiratory tract infections, and ten controls were tonsillectomized for recurrent infections or rhonchologic pathology. A three-step indirect immunofluorescence technique was used to identify and enumerate specific antibody forming cells (SAFC) in their tonsils. Plasma-cells specific of the four strains being constituents of the oral vaccine (H. influenzae, K. pneumoniae, S. pyogenes and S. pneumoniae) were observed in all samples. The numbers of SAFC were significantly higher in the subjects who had received the oral vaccine. These results support the efficiency or oral immunization in increasing local defenses, even at distance from the sensitized gut-associated lymphoid tissue. These data provide evidence for the homing phenomenon in human mucosae associated lymphoid tissue (MALT).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184137     DOI: 10.1016/0192-0561(90)90087-4

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  7 in total

Review 1.  Pharmacology of ribosomal immunotherapy.

Authors:  J Clot
Journal:  Drugs       Date:  1997       Impact factor: 9.546

2.  From Peyer's patches to tonsils. Specific stimulation with ribosomal immunotherapy.

Authors:  M C Béné; G C Faure
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 3.  Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review.

Authors:  Jean Bousquet; Alessandro Fiocchi
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Inhibition of Streptococcus pneumoniae adhesion by specific salivary IgA after oral immunisation with a ribosomal immunostimulant.

Authors:  L Hbabi-Haddioui; C Roques
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Cost effectiveness of immunoprophylaxis in the prevention of recurrent infectious rhinitis in adults.

Authors:  G Berdeaux; A Lafuma; A M Perruchet; F Fagnani
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

6.  Effectiveness of ribosomal fractions of Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction of Kp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis. Results of a multicenter double-blind placebo-controlled study.

Authors:  E Serrano; J P Demanez; A Morgon; C Chastang; P Van Cauwenberge
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

7.  Effectiveness of Polyvalent Bacterial Lysate and Autovaccines Against Upper Respiratory Tract Bacterial Colonization by Potential Pathogens: A Randomized Study.

Authors:  Olaf Zagólski; Paweł Stręk; Andrzej Kasprowicz; Anna Białecka
Journal:  Med Sci Monit       Date:  2015-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.